Ophthalmic Drugs And What They Say About EU Antitrust


Jacques Buhart, Lionel Lesur, Veronica Pinotti and Martino Sforza wrote this bylined article about how recent European Community investigations into two pharmaceutical companies selling ophthalmic drugs in Europe demonstrate strengthened cross-border cooperation and multi-jurisdictional parallel proceedings. “International groups should therefore build efficient global coordination among the local teams and offices under a single antitrust audit and compliance strategy, taking into account the specificities of each jurisdiction where they have a presence or do business,” the authors wrote.